How many insider trades does FilingIQ track for SERA?

FilingIQ tracks 313 Form 4 insider transactions for SERA (SERA PROGNOSTICS, INC.), covering filings from Jul 19, 2021 onwards. 24 of those were filed in the last 90 days.

Are SERA insiders net buyers or net sellers?

Across the full Form 4 history for SERA, 1 transactions (0%) were open-market purchases and 200 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SERA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SERA in?

SERA PROGNOSTICS, INC. (SERA) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $96.87M.

SERA insider trading

NasdaqGM Healthcare

SERA PROGNOSTICS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

313

Last 90 days

Buys / sells

0% / 64%

Market cap

$96.87M

About SERA PROGNOSTICS, INC.

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Company website: www.sera.com

SERA insider activity at a glance

FilingIQ has scored 313 insider transactions for SERA since Jul 19, 2021. The most recent filing in our index is dated Mar 12, 2026.

Across the full history, 1 open-market purchases and 200 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SERA insider trades is 56.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SERA trades on FilingIQ Raw filings on SEC EDGAR

Latest SERA Form 4 filings

Lindgardt Zhenya Chief Executive Officer

S Mar 10, 2026

Aerts Austin Chief Financial Officer

S Mar 10, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for SERA?: FilingIQ tracks 313 Form 4 insider transactions for SERA (SERA PROGNOSTICS, INC.), covering filings from Jul 19, 2021 onwards. 24 of those were filed in the last 90 days.
Are SERA insiders net buyers or net sellers?: Across the full Form 4 history for SERA, 1 transactions (0%) were open-market purchases and 200 (64%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SERA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SERA in?: SERA PROGNOSTICS, INC. (SERA) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $96.87M.

Methodology & sources

Every SERA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.